Search clinical trials for: gender-affirming estrogen

Total 3411 results

AstraZeneca

Completed

Liver Safety Under Upfront Arimidex vs Tamoxifen (HEART)

Breast Cancer

China
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group; NCIC Clinical... and other collaborators

Completed

SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer

Breast Cancer
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group; Cancer and...

Terminated

S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

Breast Cancer

United States
Pfizer

Terminated

A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women

Healthy

United States
National Cancer Institute (NCI)

Completed

2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors

Stage III Multiple Myeloma | Unspecified Adult Solid Tumor, Protocol Specific | Refractory Multiple Myeloma

United States
National Cancer Institute (NCI)

Terminated

Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer

Inflammatory Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Cardiac Toxicity

United States
Southwest Oncology Group
National Cancer Institute (NCI)

Withdrawn

S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer

Breast Cancer

United States
Medical University of Vienna

Completed

Combined Administration of Teripapartide and Antiresorptive Agents in Postmenopausal Osteoporosis (Confors)

Osteoporosis

Austria
Chulalongkorn University

Completed

Effect of Estrogen Therapy on Objective Sleep Quality in Postmenopausal Women

Insomniac Postmenopausal Women

Thailand
Rita Golfieri

Completed

Traditional (Traditional Chemoembolization) TACE Versus Microsphere TACE (PRECISION-IT)

Carcinoma, Hepatocellular

Italy
Milton S. Hershey Medical Center
Mayo Clinic

Completed

Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) Response to Low Dose Clomiphene Citrate in Normally Menstruating Fertile Women

Infertility

United States
Sun Yat-sen University
Ministry of Health, China; Guangdong Provincial People's Hospital; Kaiping Central... and other collaborators

Completed

Different Regimens of Transarterial Chemoembolization for Hepatocellular Carcinoma (TACEforHCC)

Hepatocellular Carcinoma

China
Institute for Atherosclerosis Research, Russia

Completed

Study of Anti-atherosclerotic and Estrogen-like Activity of Karinat in Perimenopausal Women (PEARS)

Atherosclerosis | Menopausal Syndrome
Massachusetts General Hospital
Dana-Farber Cancer Institute; Brigham and Women's Hospital

Completed

Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer

Ovarian Cancer | Peritoneal Carcinoma | Tubal Carcinoma

United States
Duke University
Emory University

Withdrawn

Optimizing Ovulation Induction in the Poor Responder

IVF Poor Responders

United States
Oregon Health and Science University
Oregon Clinical and Translational Research Institute

Completed

Hormonal Contraception and Vaginal Health

Contraceptive Usage | Vaginal Epithelial Disruption

United States
Pfizer

Terminated

Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast Cancer

Advanced Breast Cancer

United States, Hungary, Spain, Belgium, China, Hong Kong, Australia, Poland, Canada, India, South Africa
Pfizer

Terminated

Aromasin® As Adjuvant Treatment In Postmenopausal Women With Invasive, Estrogen Receptor Positive Early Breast Cancer

Breast Neoplasms

Serbia, Croatia, Estonia
Wageningen University

Completed

Effect of Two Different Isoflavone Supplement Preparations on Gene-expression in Postmenopausal Women (ISOII)

Postmenopause

Netherlands
Southwest Oncology Group
National Cancer Institute (NCI); Cancer and Leukemia Group B

Completed

S9630, Medroxyprogesterone in Treating Women With Breast Cancer

Breast Cancer | Endometrial Cancer

United States
Pfizer

Withdrawn

Study Of PF-04691502 (PI3K/mTOR Inhibitor) In Combination With Exemestane Compared With Exemestane Alone In Patients With Advanced Breast Cancer

Breast Neoplasms
Sun Yat-sen University
Danone Institute International; Chinese Nutrition Society; Department of Health...

Completed

The Effects of Soy Isoflavones to Improve the Metabolism of Glucose and Lipids

Type 2 Diabetes Mellitus

China
Watson Pharmaceuticals
Massachusetts General Hospital

Completed

A Comparison of Patch vs. Pill Estrogen Therapy on Testosterone Levels and Thyroid Tests in Menopausal Women

Menopause

United States
University of Washington
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

CEP-1 Hormonal Regulation of Circulating Endothelial Progenitor Cells and HDL-C in Men (CEP-1)

Healthy
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes

Breast Cancer

United States
Peking Union Medical College Hospital

Unknown

Multi-centre Clinical Trial on Hormone Replacement Treatment in China

Cardiovascular Disease | Breast Cancer | Osteoporosis | Menopausal Syndrome

China
Pfizer

Terminated

Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer Patients

Early Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI); Janssen Pharmaceuticals

Terminated

A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer

Prostate Cancer

United States
Zagazig University

Completed

Study to Compare Between Combimed Metformin-letrozole and Ovarian Drilling in Pcos With Bilateral Ovarian Drilling in Clomiphene-resistant Infertile Women With Polycystic Ovarian Syndrome

Focus of Study

Egypt
Yale University

Withdrawn

Treatment of Preterm Labor With 17 Alpha-hydroxyprogesterone Caproate

Premature Birth | Premature Labor
University of Wisconsin, Madison

Completed

Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?

Breast Cancer | Osteoporosis | Osteopenia | Fracture
University of Messina
Ministry of Education, Universities and Research, Italy

Completed

Effect of Genistein in Women With Metabolic Syndrome

Metabolic Syndrome

Italy
Estetra

Completed

Cycle Control Assessment of a Combined Oral Contraceptive Containing Estetrol and a Progestin P1 or P2 (FIESTA)

Contraception

Finland
farzaneh hojjat
Razieh dehghani firouzabadi; Robab davar

Completed

Effect of Adding Sildenafil to Protocol of Endometrial Preparation in Outcome of Frozen-thawed Embryo Transfer Cycles (sildenafil)

Frozen Embryo Transfer | Endometrial Preparation

Iran, Islamic Republic of
Vanderbilt-Ingram Cancer Center

Terminated

Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast Cancer

Hormone-sensitive Metastatic Breast Cancer

United States
Assiut University

Completed

Letrozole or Combined Clomiphene Citrate Metformin as a First Line Treatment in Women With Polycystic Ovarian Syndrome (PCO)

Polycystic Ovary Syndrome

Egypt
AstraZeneca

Completed

Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment

Breast Cancer

Japan
University of Valencia

Completed

Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal Osteoporosis

Postmenopausal Osteoporosis | Compliance

Spain
AstraZeneca

Completed

Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer

Breast Cancer

United Kingdom
University of Messina
Ministry of Education, Universities and Research, Italy

Completed

Effects of Genistein in Postmenopausal Women With Metabolic Syndrome

Metabolic Syndrome

Italy
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Terminated

PhII Neo-Adjuvant Letrozole & Lapatinib in Pts w/HER2+ & Hormone Receptor+ Operable Breast CA SPORE

Breast Cancer

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Terminated

Ph II Letrozole + OSI-774 (Tarceva) in Post-menopausal, w/ ER and/or PR-positive Met Breast Cancer.

Breast Cancer

United States
Tianjin Medical University

Unknown

Efficacy and Safety of TAC and Exemestane as Neoadjuvant Chemotherapy in the Postmenopausal Women With Breast Cancer

Breast Cancer

China
Cardiovascular Imaging Technologies
Astellas Pharma US, Inc.

Unknown

Lexiscan(TM) Rb-82 Myocardial Perfusion PET: A Comparison With Dipyridamole Stress

Coronary Artery Disease

United States
AstraZeneca

Completed

Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy (FACT)

Breast Cancer

Sweden, France, Italy, Turkey, Germany, Norway, Finland, Portugal, Canada, Iceland, Costa Rica, Guatemala
Mayo Clinic
GlaxoSmithKline

Completed

Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men

Aging

United States
AstraZeneca

Completed

Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma.

Endometrial Carcinoma

Germany
Tianjin Medical University

Unknown

Research of Zoledronic Acid and Aromatase Inhibitors as Adjuvant Therapy to Breast Cancer (esozao)

Breast Cancer

China
M.D. Anderson Cancer Center

Withdrawn

Molecular Triaging of Newly Diagnosed Breast Cancer

Breast Cancer
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Chemoprevention Therapy Plus Surgery in Treating Women With Breast Cancer

Breast Cancer

United States

Search clinical trials for: gender-affirming estrogen

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations